Table 3.
Relation of fracture risk with serum concentration of bone turnover markers among early postmenopausal women using linear regression model
| Variable | Adjusted β | Nonadjusted β | ||
|---|---|---|---|---|
|
|
|
|||
| 95% CI | P | 95% CI | P | |
| Major osteoporotic fracture | ||||
| OC | 0.019 (0.002–0.036) | 0.031 | 0.032 (0.013–0.051) | <0.001 |
| OP | 0.033 (0.004–0.063) | 0.027 | 0.048 (0.013–0.082) | 0.007 |
| ALP | 0.002 (−0.002–0.006) | 0.229 | 0.003 (−0.001–0.008) | 0.134 |
| Hip fracture | ||||
| OC | 0.005 (0.004–0.012) | <0.001 | 0.012 (0.008–0.017) | <0.001 |
| OP | 0.012 (0.004–0.19) | 0.002 | 0.016 (0.008–0.024) | <0.001 |
| ALP | 0.001 (0.000–0.002) | 0.079 | 0.001 (0.000–0.002) | 0.009 |
Adjusted for age, BMI, and menopause age. ALP=Alkaline phosphatase; CI=Confidence interval; BMI=Body mass index; OC=Osteocalcin; OP=Osteopontin